These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
287 related items for PubMed ID: 17143813
1. Routine use of the Pneumonia Severity Index for guiding the site-of-treatment decision of patients with pneumonia in the emergency department: a multicenter, prospective, observational, controlled cohort study. Renaud B, Coma E, Labarere J, Hayon J, Roy PM, Boureaux H, Moritz F, Cibien JF, Guérin T, Carré E, Lafontaine A, Bertrand MP, Santin A, Brun-Buisson C, Fine MJ, Roupie E, Pneumocom Study Investigators. Clin Infect Dis; 2007 Jan 01; 44(1):41-9. PubMed ID: 17143813 [Abstract] [Full Text] [Related]
2. Reasons why emergency department providers do not rely on the pneumonia severity index to determine the initial site of treatment for patients with pneumonia. Aujesky D, McCausland JB, Whittle J, Obrosky DS, Yealy DM, Fine MJ. Clin Infect Dis; 2009 Nov 15; 49(10):e100-8. PubMed ID: 19842971 [Abstract] [Full Text] [Related]
3. The hospital admission decision for patients with community-acquired pneumonia. Results from the pneumonia Patient Outcomes Research Team cohort study. Fine MJ, Hough LJ, Medsger AR, Li YH, Ricci EM, Singer DE, Marrie TJ, Coley CM, Walsh MB, Karpf M, Lahive KC, Kapoor WN. Arch Intern Med; 1997 Jan 13; 157(1):36-44. PubMed ID: 8996039 [Abstract] [Full Text] [Related]
4. Clinical judgment versus the Pneumonia Severity Index in making the admission decision. Seymann G, Barger K, Choo S, Sawhney S, Davis D. J Emerg Med; 2008 Apr 13; 34(3):261-8. PubMed ID: 18180134 [Abstract] [Full Text] [Related]
5. Treatment failure rates and health care utilization and costs among patients with community-acquired pneumonia treated with levofloxacin or macrolides in an outpatient setting: a retrospective claims database analysis. Ye X, Sikirica V, Schein JR, Grant R, Zarotsky V, Doshi D, Benson CJ, Riedel AA. Clin Ther; 2008 Feb 13; 30(2):358-71. PubMed ID: 18343274 [Abstract] [Full Text] [Related]
6. Alveolar-arterial oxygen gradient, pneumonia severity index and outcomes in patients hospitalized with community acquired pneumonia. Moammar MQ, Azam HM, Blamoun AI, Rashid AO, Ismail M, Khan MA, DeBari VA. Clin Exp Pharmacol Physiol; 2008 Sep 13; 35(9):1032-7. PubMed ID: 18518885 [Abstract] [Full Text] [Related]
7. Moxifloxacin monotherapy is effective in hospitalized patients with community-acquired pneumonia: the MOTIV study--a randomized clinical trial. Torres A, Garau J, Arvis P, Carlet J, Choudhri S, Kureishi A, Le Berre MA, Lode H, Winter J, Read RC, MOTIV (MOxifloxacin Treatment IV) Study Group. Clin Infect Dis; 2008 May 15; 46(10):1499-509. PubMed ID: 18419482 [Abstract] [Full Text] [Related]
8. Utility of a pneumonia severity index in the optimization of the diagnostic and therapeutic effort for community-acquired pneumonia. Ortega L, Sierra M, Domínguez J, Martínez J, Matas L, Bastart F, Galí N, Ausina V. Scand J Infect Dis; 2005 May 15; 37(9):657-63. PubMed ID: 16126566 [Abstract] [Full Text] [Related]
9. [Clinical policy for management and risk stratification of community-acquired pneumonia in patients hospitalized on the basis of conventional admission criteria]. Putinati S, Ballerin L, Piattella M, Ritrovato L, Zabini F, Potena A. Recenti Prog Med; 2003 May 15; 94(5):199-203. PubMed ID: 12723497 [Abstract] [Full Text] [Related]
10. Initial antibiotic selection and patient outcomes: observations from the National Pneumonia Project. Bratzler DW, Ma A, Nsa W. Clin Infect Dis; 2008 Dec 01; 47 Suppl 3():S193-201. PubMed ID: 18986289 [Abstract] [Full Text] [Related]
11. Outcome predictors of pneumonia in elderly patients: importance of functional assessment. Torres OH, Muñoz J, Ruiz D, Ris J, Gich I, Coma E, Gurguí M, Vázquez G. J Am Geriatr Soc; 2004 Oct 01; 52(10):1603-9. PubMed ID: 15450034 [Abstract] [Full Text] [Related]
13. Admission D-dimer can identify low-risk patients with community-acquired pneumonia. Chalmers JD, Singanayagam A, Scally C, Hill AT. Ann Emerg Med; 2009 May 01; 53(5):633-8. PubMed ID: 19201061 [Abstract] [Full Text] [Related]
14. Levofloxacin versus ceftriaxone plus clarithromycin in the treatment of adults with community-acquired pneumonia requiring hospitalization. Querol-Ribelles JM, Tenías JM, Querol-Borrás JM, Labrador T, Nieto A, González-Granda D, Martínez I. Int J Antimicrob Agents; 2005 Jan 01; 25(1):75-83. PubMed ID: 15620830 [Abstract] [Full Text] [Related]
17. A validation and potential modification of the pneumonia severity index in elderly patients with community-acquired pneumonia. Naito T, Suda T, Yasuda K, Yamada T, Todate A, Tsuchiya T, Sato J, Chida K, Nakamura H. J Am Geriatr Soc; 2006 Aug 01; 54(8):1212-9. PubMed ID: 16913987 [Abstract] [Full Text] [Related]
18. Levofloxacin 750-mg for 5 days for the treatment of hospitalized Fine Risk Class III/IV community-acquired pneumonia patients. Shorr AF, Khashab MM, Xiang JX, Tennenberg AM, Kahn JB. Respir Med; 2006 Dec 01; 100(12):2129-36. PubMed ID: 16730170 [Abstract] [Full Text] [Related]
19. Etiology, reasons for hospitalization, risk classes, and outcomes of community-acquired pneumonia in patients hospitalized on the basis of conventional admission criteria. Rosón B, Carratalà J, Dorca J, Casanova A, Manresa F, Gudiol F. Clin Infect Dis; 2001 Jul 15; 33(2):158-65. PubMed ID: 11418874 [Abstract] [Full Text] [Related]
20. A teaching hospital's experience applying the Pneumonia Severity Index and antibiotic guidelines in the management of community-acquired pneumonia. Lee RW, Lindstrom ST. Respirology; 2007 Sep 15; 12(5):754-8. PubMed ID: 17875067 [Abstract] [Full Text] [Related] Page: [Next] [New Search]